(CNN) — Disruptions from Hurricane Helene exacerbated shortages of critical intravenous fluids in the United States, and now the Biden administration has invoked the wartime powers of the Defense ...

NEXT WEEK ARE NOW GOING TO BE DELAYED. I.V. FLUID IS LIKE A LIFELINE TO PATIENTS. THAT LIFELINE IS IN SHORT SUPPLY AND NOW IMPACTING PATIENTS WHO HAVE NON-EMERGENCY SURGERIES SCHEDULED AT MASS.

Raw vs. kibble vs. fresh dog food: honest comparison of costs, health benefits, and what works. Which diet adds 3+ years to your dog's life?

Hurricane Helene left a trail of devastation and destruction last year, dumping 40 trillion gallons of water on the Southeast. It leveled houses, sent trees crashing and left millions without power.

The article by Ailawadhi et al titled “Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III ...

TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer's disease, ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with patient-specific factors guiding delivery method choices, while ongoing innovation and ...

When deciding whether to use subcutaneous (SubQ) or intravenous (IV) therapies, clinicians must weigh several clinical and practical factors. One of the first considerations is the type of cancer ...

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study Patients with ≥1 prior line of therapy were ...

IV therapy for weight loss involves administering vitamins, minerals, or medications directly into your vein. There are no official guidelines for its use in weight loss, and very limited research ...

Ohio medical regulators have a warning for the growing number of retail IV hydration clinics in the state: They’re practicing medicine and pharmacy, and if they don’t follow the rules, they could face ...

Lundbeck has stopped development of a subcutaneous formulation of its migraine drug Lu AG09222 as the Danish drugmaker switches its focus to intravenous delivery after seeing phase 2b data, delaying ...